DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Earnings per Share - DRIO ranking 43 / 57

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
36.37
2. Thermo Fisher Scientific TMO
16.1
3. Medpace Holdings MEDP
10.63
4. IDEXX Laboratories IDXX
10.32
5. Waters WAT
10.01
6. Icon ICLR
8.6
7. Charles River Laboratories CRL
8.5
8. IQVIA Holdings IQV
7.7
9. Quest Diagnostics DGX
7.41
10. Lantheus Holdings LNTH
6.08
11. Danaher DHR
5.45
12. Laboratory Corp of America Holdings LH
5.39
13. Trinity Biotech TRIB
4.25
14. Agilent Technologies A
4.21
15. PerkinElmer PKI
2.78
16. DexCom DXCM
1.61
17. Qiagen QGEN
1.52
18. National Research NRC
1.24
19. Syneos Health SYNH
0.7
20. Global Cord Blood CO
0.59
21. RadNet RDNT
0.37
22. Interpace Biosciences IDXG
0.28
23. Sotera Health SHC
0.19
24. Ortho Clinical Diagnostics Holdings OCDX
0
25. Neogen NEOG
-0.04
26. Olink Holding OLK
-0.27
27. Bioventus BVS
-0.33
28. MaxCyte MXCT
-0.35
29. Enzo Biochem ENZ
-0.35
30. Anixa Biosciences ANIX
-0.37
31. Biodesix BDSX
-0.54
32. NeoGenomics NEO
-0.62
33. Psychemedics PMD
-0.77
34. bioAffinity Technologies BIAF
-0.93
35. Neuronetics STIM
-0.94
36. Exact Sciences EXAS
-0.95
37. Sera Prognostics SERA
-1.07
38. Exagen XGN
-1.09
39. Pacific Biosciences of California PACB
-1.14
40. Co-Diagnostics CODX
-1.31
41. Aspira Womens Health AWH
-1.41
42. MDxHealth MDXH
-1.44
43. DarioHealth DRIO
-1.68
44. Personalis PSNL
-1.9
45. Heska HSKA
-1.92
46. Organovo Holdings ONVO
-2.16
47. Inotiv NOTV
-2.77
48. Myriad Genetics MYGN
-2.8
49. CareDx CDNA
-2.98
50. Natera NTRA
-3.11
51. Precipio PRPO
-3.36
52. Twist Bioscience TWST
-3.36
53. Guardant Health GH
-3.92
54. Prenetics Global PRE
-4.28
55. Fulgent Genetics FLGT
-5.56
56. Illumina ILMN
-8.15
57. SeqLL SQL
-16.4

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.